Concepedia

Christopher W. Ho

CW

Statistics

Publications

2

Citations

89

H-Index

2

Active since

2008

Affiliations

GlaxoSmithKline (Italy)(Current)

Christopher W. Ho is an author at GlaxoSmithKline (Italy) specializing in neuropharmacology, homeostatic appetite control, and appetite.

Publications per year

2008–2014

2

Publications

2

The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity

Panayotis K. Thanos, Michael Michaelides, Christopher W. Ho et al. · Pharmacology Biochemistry and Behavior · 2008 · 47 citations · Full text

, , +16

Ceftolozane/Tazobactam: a new option in the treatment of complicated gram-negative infections.

Maria Sorbera, Elizabeth Chung, Christopher W. Ho et al. · PubMed · 2014 · 42 citations

, , +10

1–2 of 2